Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1960 1
1966 1
1973 2
1977 1
1980 1
1981 1
1983 3
1984 6
1985 10
1986 7
1987 5
1988 6
1989 7
1990 16
1991 18
1992 9
1993 18
1994 14
1995 7
1996 8
1997 13
1998 24
1999 24
2000 34
2001 33
2002 34
2003 52
2004 70
2005 87
2006 116
2007 132
2008 144
2009 172
2010 197
2011 196
2012 281
2013 326
2014 415
2015 465
2016 484
2017 553
2018 630
2019 706
2020 825
2021 963
2022 1031
2023 1057
2024 1239
2025 1350
2026 1001
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,442 results

Results by year

Filters applied: . Clear all
Page 1
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Yue D, Huang M, Song P, Chen Y, Li B, Fu J, Guo J, Cheng C, Chen Q, Xu S, Liu H, Lv F, Hu J, Jiang K, Mao W, Shen B, Ye F, Li J, Zhang X, Guo S, Yu B, Zhu Y, Wu M, Zheng W, Chen F, He Z, Bai Y, Xin H, Chen K, Mao N, Zhang Y, Wang B, Zhang L, Chen X, Mei X, Miao L, Wang R, Li G, Yao J, Zhao J, Chen C, Liu J, Wei L, Yan X, Jin B, Liu X, Liu Z, Tian H, Xing W, Yang L, Ge D, Li X, Li S, Song Y, Zang A, Zhang D, Zhuang W, Liu Z, Yuan X, Fu T, Shen Z, Zhang X, Cao Q, Zhao L, Mao L, Ding L, Lu Y, Wang C; ELEVATE Study Group. Yue D, et al. Among authors: ding l. N Engl J Med. 2026 Jul 9;395(2):151-161. doi: 10.1056/NEJMoa2518990. N Engl J Med. 2026. PMID: 42418775 Clinical Trial.
Charting human cellular senescence in aging and disease.
Suryadevara V, Farzad N, Yang M, Xu K, Tsankov A, Thompson RC, Sloan N, Phatnani H, Olinger B, Mares JA, Lund AN, Li D, Gorospe M, Ding L, Beckmann N, Basisty N, Anerillas C; NIH SenNet consortium; Robbins P, Fan R. Suryadevara V, et al. Among authors: ding l. Cell. 2026 Jun 11;189(12):3501-3505. doi: 10.1016/j.cell.2026.05.028. Cell. 2026. PMID: 42276030 Review.
Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets.
Chu SA, Hsiao Y, Wang C, Kyle JE, Jain R, Deng Y, Gritsenko MA, Henry LE, Lei JT, Dou Y, Tercan B, Shi Z, Gondal MN, Tsai CF, Elizarraras JM, Chu RK, Yu F, Joshi SK, Jing X, Polasky DA, Weitz KK, Li GX, Paurus VL, Clendinen CS, Schepmoes AA, Lalli PM, Eder JG, Flores JE, Stratton KG, Pino JC, Posso C, Petyuk VA, Sagendorf TJ, Xu Y, Ibrahim OM, Moore RJ, Zhao R, Chen J, Monroe ME, Thiagarajan M, Hostetter G, Newton C, An E, Robles AI, Zhang X, Edwards NJ, Lu Y, Zhang H, Abdelhakim H, Piehowski PD, Mesri M, Smith RD, Kumar-Sinha C, Tognon CE, Dunlap J, Traer E, Ding L, Tyner JW, Chinnaiyan AM, Omenn GS, Rodland KD, Dhanasekaran SM, Gosline SJC, Nesvizhiskii AI, Zhang B, Liu T, Cieslik MP; Clinical Proteomic Tumor Analysis Consortium. Chu SA, et al. Among authors: ding l. Nat Cancer. 2026 Jun;7(6):993-1015. doi: 10.1038/s43018-026-01175-6. Epub 2026 Jun 12. Nat Cancer. 2026. PMID: 42286338 Free PMC article.
Tumor cells metabolically resist immune-checkpoint therapy by macrophage efferocytosis-mediated fatty acid recycling.
Liang Z, Long X, Xiong Z, Wong PP, Huang S, Chen S, Zhang Y, Zhang L, Leung C, Cao J, Wu H, Yue H, Zhao Z, Tu Y, Yin B, Yang W, Wang J, Chen S, Zhang X, Tsang YW, Zhong C, Liu X, Ding L, Lu J, Si-Tou WW, Liu Y, Wang Y, Lin Y, Liang J, Ren W, Vong JS, Tong M, Tian X, Hui HX, Zhou J, Ngai S, Ni S, To KF, Braun T, Jao-Yiu Sung J, Chan SL, Cheng AS. Liang Z, et al. Among authors: ding l. Cancer Cell. 2026 Jun 8;44(6):1235-1254.e11. doi: 10.1016/j.ccell.2026.05.005. Cancer Cell. 2026. PMID: 42259249 Free article.
Luminal surface proteome of the brain vasculature uncovers blood-brain barrier regulators.
Zhu Z, Jiang Z, Wang Y, Nguyen K, Zhang Y, Lian CG, Mani DR, Zheng J, Ding L, Gao SM, Xia RA, Kuszpit A, Lindo S, Lopez C, Lindsey C, Groff B, Chen X, Wu J, Xia W, Li W, Liu X, Gradinaru V, Carr SA, Udeshi ND, Li J. Zhu Z, et al. Among authors: ding l. Science. 2026 Apr 9;392(6794):eaea2100. doi: 10.1126/science.aea2100. Epub 2026 Apr 9. Science. 2026. PMID: 41955380 Free PMC article.
Clinical utility of molecular residual disease detection in early-stage resected EGFR-mutated non-small cell lung cancer.
Zhou F, Su C, Liang W, Xu LD, Tao W, Qian J, Xu S, Liu D, Fan R, Zhang Y, Liu Y, Wu L, Fu X, Zhang X, Shen N, Ge D, Chen Q, Mao W, Xu L, Chen C, Hu B, Shao G, Hu J, Zhao J, Liu X, Liu Z, Wang Z, Xiao Z, Gong T, Lin W, Li X, Ye F, Liu Y, Ma H, Huang Y, Zhou J, Wang Z, Fu J, Ding L, Mao L, Chen W, He J, Zhou C. Zhou F, et al. Among authors: ding l. Nat Commun. 2026 Aug 10;17(1):9561. doi: 10.1038/s41467-026-76392-9. Nat Commun. 2026. PMID: 42706268 Free PMC article. Clinical Trial.
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.
Chaft JE, Sun Z, Rudin CM, Khullar OV, Simone CB 2nd, Oettel K, Kozono D, Sunkara R, Faller B, Isbell JM, Hugec V, Shipstone A, McGary EC, Clarke JM, Talsania A, Ding L, Govindan R, Sands JM, Heymach JV, Raez LE, Malik SM, Stinchcombe TE, Mandrekar SJ, Bradley J, Gerber DE, Vokes E, Gandara D, Staley C, Ramalingam SS. Chaft JE, et al. Among authors: ding l. JAMA. 2026 Aug 11;336(6):464-472. doi: 10.1001/jama.2026.8992. JAMA. 2026. PMID: 42224490 Free PMC article. Clinical Trial.
11,442 results
You have reached the last available page of results. Please see the User Guide for more information.